Bridgefront Capital’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.79M Buy
+16,808
New +$2.04M 0.47% 44
2025
Q4
Sell
-1,425
Closed -$205K 652
2025
Q3
$205K Buy
+1,425
New +$175K 0.06% 513
2024
Q4
Sell
-6,028
Closed -$440K 681
2024
Q3
$440K Buy
6,028
+1,228
+26% +$90.6K 0.17% 215
2024
Q2
$322K Buy
+4,800
New +$186K 0.13% 274
2023
Q1
Sell
-16,470
Closed -$329K 499
2022
Q4
$329K Buy
+16,470
New +$318K 0.23% 185
2021
Q2
Sell
-9,150
Closed -$312K 744
2021
Q1
$312K Buy
+9,150
New +$350K 0.1% 412

Other funds holding INSM

Bridgefront Capital's INSM Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Insmed (INSM) in Q2 2026: 16,808 shares worth $1.79M. The stake represents 0.47% of the portfolio and ranks #44 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in INSM as recently as Q3 2025.

Bridgefront Capital first reported a position in INSM in Q1 2021 and has held it in 6 quarters since. 665 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Bridgefront Capital held 16,808 shares of Insmed worth $1.79M as of Q2 2026.
  • Insmed was a new Bridgefront Capital position in Q2 2026.
  • Insmed made up 0.47% of Bridgefront Capital's portfolio in Q2 2026, its #44 holding.
  • Bridgefront Capital first reported a position in Insmed in Q1 2021 and has held it in 6 quarters since.
  • 665 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.